MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula:wherein R1, R2, R3, R5, R6, R8, M1, M2, M3, M4, M5, M6 and M7 are each independently a member selected from the group consisting of H, C1-6 alkyl, OH and C1-6...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
14.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula:wherein R1, R2, R3, R5, R6, R8, M1, M2, M3, M4, M5, M6 and M7 are each independently a member selected from the group consisting of H, C1-6 alkyl, OH and C1-6 hydroxyalkyl; R4, R7 and R9 are each independently selected from the group consisting of C1-6 alkoxy and OH; R10 is a member selected from the group consisting of H, -OH, -OP(O)Me2,-O-(CH2)n-OH and -O-(CH2)m-O-(CH2)o-CH3, wherein subscripts n and m are each independently from 2 to 8 and subscript o is from 1 to 6; each of L1 and L4 are independently selected from the group consisting of:wherein each M8 is independently a member selected from the group consisting of C1-6 alkyl, OH and C1-6 hydroxyalkyl; each of L2 and L3 are independently selected from the group consisting of:and salts, hydrates, isomers, metabolites, N-oxides and prodrugs thereof. |
---|---|
AbstractList | The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula:wherein R1, R2, R3, R5, R6, R8, M1, M2, M3, M4, M5, M6 and M7 are each independently a member selected from the group consisting of H, C1-6 alkyl, OH and C1-6 hydroxyalkyl; R4, R7 and R9 are each independently selected from the group consisting of C1-6 alkoxy and OH; R10 is a member selected from the group consisting of H, -OH, -OP(O)Me2,-O-(CH2)n-OH and -O-(CH2)m-O-(CH2)o-CH3, wherein subscripts n and m are each independently from 2 to 8 and subscript o is from 1 to 6; each of L1 and L4 are independently selected from the group consisting of:wherein each M8 is independently a member selected from the group consisting of C1-6 alkyl, OH and C1-6 hydroxyalkyl; each of L2 and L3 are independently selected from the group consisting of:and salts, hydrates, isomers, metabolites, N-oxides and prodrugs thereof. |
Author | Yan, John Bhat, Vinayak D Zheng, Xiaoxia |
Author_xml | – fullname: Yan, John – fullname: Bhat, Vinayak D – fullname: Zheng, Xiaoxia |
BookMark | eNrjYmDJy89L5WQw93V0DvJ3jnT28XRW8HF0DvH3c1Vw9vcN8A_1cwlWcPRzUfB1DfHwB7Ld_IMUQjxcPYMUQoNdeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGRoYGBhYGJgaOhMXGqAN8KKrA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2021008040A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2021008040A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:35:18 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2021008040A13 |
Notes | Application Number: US202016879115 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210114&DB=EPODOC&CC=US&NR=2021008040A1 |
ParticipantIDs | epo_espacenet_US2021008040A1 |
PublicationCentury | 2000 |
PublicationDate | 20210114 |
PublicationDateYYYYMMDD | 2021-01-14 |
PublicationDate_xml | – month: 01 year: 2021 text: 20210114 day: 14 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | Elixir Medical Corporation |
RelatedCompanies_xml | – name: Elixir Medical Corporation |
Score | 3.3001091 |
Snippet | The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula:wherein R1, R2,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210114&DB=EPODOC&locale=&CC=US&NR=2021008040A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkDpW7Fzadc-DOnSjE7WZqytzKeRfoEg3XAV_32vddM97S3JwXEJ3MfvkrsAPOjyycp1PVEtiiaQUktTLbMrVbOXm0kmJXrAKjXg-YYb0Ze5Pm_Ax7YWpu4T-l03R0SNSlDfy9per_6TWE79tnL9GL_j0vJ5FA4cZYOOEb9gfK84wwGfCkcwhbFBFCj-7JeG0RHVbMRKB1UgXXXa56_Dqi5ltetURqdwOEV-RXkGjaxowTHb_r3WgiNvc-WNw432rc-h79lsJtgbm4wZmdgsFD4nTHhTEflOQGzfIR4PXYFjxHYkdPl4RqKAX8D9iIfMVVGCxd-GF1GwK27vEprFssiugMjYiLM8M3KDptTIdZmaWl_mvUQmWmrStA2dfZyu95Nv4KSaVgmGLu1As_z8ym7R5ZbxXX1SP3GVfyA |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-Kj6oKSWzC1mzQ5FEk3Kakm2dIkUk9l8wJB0mIj_n0nsdWeeht2YJhdmMc3uzMLcK-KRyNX1UQ2KLpASg1FNvSukPVerieZEBgBq9KA52tORJ9n6qwBH5temHpO6Hc9HBEtKkF7L2t_vfwvYln128rVQ_yOS4unUTiwpDU6RvyC-b1kDQf2hFucSYwNokDyp788zI6oYiJW2utX83mr5Ol1WPWlLLeDyugI9icoryiPoZEVbWixzd9rbTjw1lfeSK6tb3UCfc9kU87emDtmxDVZyH2bMO5NeORbATF9i3h26HCkEduR0LHHUxIF9incjeyQOTJqMP_b8DwKttXtnUGzWBTZORARa3GWZ1qu0ZRquSpSXemLvJeIREl1ml5AZ5eky93sW2g5oefO3bH_cgWHFasqNnRpB5rl51d2jeG3jG_qU_sBjD6CDQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MACROCYCLIC+LACTONE+COMPOUNDS+AND+METHODS+FOR+THEIR+USE&rft.inventor=Yan%2C+John&rft.inventor=Bhat%2C+Vinayak+D&rft.inventor=Zheng%2C+Xiaoxia&rft.date=2021-01-14&rft.externalDBID=A1&rft.externalDocID=US2021008040A1 |